Novel beta-blocker pretreatment prevents alcohol-induced atrial fibrillation in a rat modelKey Findings
Background: A case report published in 2019 described a patient who presented with difficult-to-manage atrial fibrillation (AF) that consistently was associated with alcohol consumption. After the patient did not respond to drug therapy, a novel beta-blocker (BB) pretreatment regimen initiated immed...
Main Authors: | Hebah Hassan, BS, Lisa V. Greco, MS, Daniel I. Meshoyrer, DO, Ying Li, BS, Youhua Zhang, MD, PhD, Todd J. Cohen, MD, FHRS |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Heart Rhythm O2 |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666501820300106 |
Similar Items
-
Observational study of new-onset atrial fibrillation in patients treated with Ivabradine alone versus Ivabradine and β-blocker drug (The BetaBrad Study)
by: Rohan S Thanedar, et al.
Published: (2022-01-01) -
Which beta-blocker should be used for the prevention of postoperative atrial fibrillation in cardiac surgery? A multi-treat
by: Mohamed Zeinah, et al.
Published: (2016-06-01) -
Long-term observation of fibrillation cycle length in patients under angiotensin II receptor blocker therapy for chronic atrial fibrillation
by: Jun Kishihara, et al.
Published: (2012-02-01) -
Organization of atrial fibrillation using a pure sodium channel blocker: Implications of rotor ablation therapy
by: Tadafumi Nanbu, et al.
Published: (2023-06-01) -
Novel rate control strategy with landiolol in patients with cardiac dysfunction and atrial fibrillation
by: Teruhiko Imamura, et al.
Published: (2020-10-01)